Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Long-acting anticholinergics (LAMAs) treat COPD by blocking muscarinic M3 receptors on airway smooth muscle, preventing acetylcholine from tightening airways and sustaining bronchodilation for 12–24 hours. Their quaternary ammonium structure and lipophilic side chains anchor the drug to the receptor, enabling once- or twice-daily dosing that improves airflow, reduces symptoms and flare-ups, and enhances quality of life.
Understanding whether your symptoms point to COPD—or another condition entirely—is the critical first step before considering any treatment. Because respiratory symptoms like breathlessness, cough, and wheezing can overlap with asthma, heart conditions, or infections, getting clarity early can help you avoid delays in the right care. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/09/2026
Long-acting anticholinergics (LAACs) are a mainstay in treating chronic obstructive pulmonary disease (COPD) and improving lung function. They work by blocking specific nerve signals that cause bronchial muscles to tighten, keeping airways open longer. Below, we explore in clear, common language how these drugs work, why they last so long, and what it means for people managing breathing issues.
Our airways are lined with smooth muscle that contracts or relaxes to change airflow. Two major systems regulate this:
Parasympathetic (cholinergic) nerves
– Release acetylcholine (ACh)
– ACh binds to muscarinic receptors (mainly M3) on airway smooth muscle
– Stimulates muscle contraction → bronchoconstriction
Sympathetic (adrenergic) nerves
– Release norepinephrine
– Activates β₂-adrenergic receptors → muscle relaxation → bronchodilation
In healthy people, these systems balance each other. In COPD or chronic bronchitis, parasympathetic (cholinergic) tone is often heightened, leading to narrowed airways and difficulty breathing.
At their core, LAACs interrupt the cholinergic "tightening" signal:
Receptor blockade
Prolonged action
Result
| Drug | Usual Duration | Typical Dosing |
|---|---|---|
| Tiotropium | ~24 hours | Once daily |
| Aclidinium | ~12 hours | Twice daily |
| Glycopyrronium | ~24 hours | Once daily |
| Umeclidinium | ~24 hours | Once daily |
While generally well tolerated, common side effects relate to anticholinergic activity elsewhere in the body:
Because systemic absorption is low, serious side effects are uncommon. Always use inhalers as prescribed and rinse your mouth after use to minimize local irritation.
If breathing worsens suddenly or you notice:
…you can quickly check your symptoms with an AI-powered assessment tool to better understand what's happening and decide your next steps. However, if you experience life-threatening breathing difficulty or severe chest pain, call emergency services immediately.
Always discuss your treatment plan and any concerns with a healthcare professional. If you suspect serious or life-threatening symptoms, seek medical attention without delay.
(References)
* Cazzola M, Calzetta L, Matera MG. Tiotropium, glycopyrronium, aclidinium and umeclidinium: a comparative review of long-acting muscarinic antagonist bronchodilators in COPD. Respir Med. 2015 Apr;109(4):440-50. doi: 10.1016/j.rmed.2015.01.011. Epub 2015 Jan 28. PMID: 25701886.
* Gavaldà A, Miralpeix M. The pharmacological profile of aclidinium bromide. Expert Rev Clin Pharmacol. 2014 Nov;7(6):747-58. doi: 10.1586/17512433.2014.970221. Epub 2014 Oct 24. PMID: 25345758.
* Donohue JF. Anticholinergics in COPD: an evidence-based review. COPD. 2005;2(1):111-27. doi: 10.1081/COPD-200050854. PMID: 17186835.
* Gosens R, Zaagsma J, Meurs H. Muscarinic receptor subtypes and their function in airway smooth muscle. Respir Res. 2005 Nov 10;6(1):129. doi: 10.1186/1465-9921-6-129. PMID: 16280097.
* Gross NJ. Targeting muscarinic receptors in asthma and COPD. Curr Opin Pharmacol. 2004 Jun;4(3):233-9. doi: 10.1016/j.coph.2004.02.007. PMID: 15157778.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.